Mediastinal lymphadenopathy detected with an integrated positron emission tomographic/computed tomographic scan: a

K Y Wong1, K S Yee, H N Tse

  • 1Integrated Medical Services, Kwong Wah Hospital, 25 Waterloo Road, Kowloon, Hong Kong. kingeffie@yahoo.com

Insights

Integrated positron emission tomography and computed tomography (PET-CT) is a common tool for lung opacities. This case highlights potential diagnostic limitations and differential diagnoses for mediastinal masses.

Area of Science:

  • Radiology
  • Oncology

Background:

  • Integrated positron emission tomography and computed tomography (PET-CT) is a standard non-invasive imaging modality for evaluating lung opacities.
  • It aids in diagnosing conditions like lung cancer and assessing mediastinal lymph node involvement.
  • The technology offers advantages such as avoiding contrast reactions.

Observation:

  • A patient presented with fever, septicaemia, and a left apical lung opacity.
  • Initial PET-CT scans revealed increased uptake in the lung opacity and a large anterior mediastinal mass.
  • A subsequent contrast-enhanced CT scan showed no significantly enlarged mediastinal lymph nodes, creating a diagnostic discrepancy.

Findings:

  • The initial PET-CT findings were suggestive of lung cancer with mediastinal metastasis.
  • However, the absence of enlarged mediastinal nodes on contrast CT challenged this diagnosis.
  • This discrepancy underscores the limitations of standalone PET-CT and the need for further investigation.

Implications:

  • This case emphasizes the importance of considering differential diagnoses when interpreting PET-CT findings, especially in the presence of conflicting imaging results.
  • It highlights the limitations of PET-CT in accurately staging mediastinal involvement in all cases.
  • Further diagnostic procedures may be necessary to resolve ambiguities and ensure appropriate patient management.